Phase I Trial of Escalating Doses of Paclitaxel Combined With Fixed Doses of Cisplatin and Doxorubicin in Advanced Endometrial Cancer and Other Gynecologic Malignancies: A Gynecologic Oncology Group ...
WHEN resident surgeons are taught the performance of transurethral prostatic resection at the University of Michigan Hospital and when matters pertaining to resection are discussed with visiting ...
Heat maps of PSMA PET prostatic fossa recurrence in patients with recurrence limited to the prostate fossa (miTr N0 M0, n=127), pelvic nodal disease (miTr N1 M0, n=30), distant organs/extra-pelvic ...
A routine test revealed a prostate-specific antigen (PSA) of 11.5 in a 56-year-old man. Two weeks later, his PSA was 12.1, with a free PSA of 0.4. Ultrasound showed a prostate volume of 29 cm, with a ...
Patient undergoing PET/CT Investigators zero in on which patients might benefit most from PSMA-PET-guided salvage radiation therapy for post-RP recurrent prostate cancer. Study findings presented at ...
Pelvic lymph node dissection (PLND) has an important role in staging and therapy of prostate cancer, especially for high-risk disease. A novel tool has been proposed to correctly predict the ...
RESTON, Va. - For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference. In a study featured in the December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback